Anke Biological: Senior executive Yao Jianping reduces holdings by 0.06%

Anke Biology announced that its senior management, Yao Jianping, has sold 1 million shares at an average price of 10.94 yuan per share through centralized bidding from November 13th to November 14th, 2025, accounting for 0.06% of the company's total share capital. The selling plan has been completed. Before the sale, Yao held 6.7622 million shares, accounting for 0.40%, and after the sale, he holds 5.7622 million shares, accounting for 0.34%. Of these, the unrestricted shares have decreased from 1.789 million to 0.789 million, while the restricted shares remain at 4.9733 million. The selling plan was disclosed on September 4th, 2025, with a planned maximum sale of 1 million shares.